Skip to content

fenugreek extract effect on pain relief

Study of the slow release fenugreek (Trigonella foenum-graecum ) seed formulation on pain relief in patients with temporomandibular disorder

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20181218042039N1
Enrollment
60
Registered
2019-04-27
Start date
2019-03-01
Completion date
Unknown
Last updated
2019-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Temporomandibular disorders. Temporomandibular joint disorder, unspecified

Interventions

Intervention 1: Intervention group: Fenugreek seed extract, with amount of 600 mg in each capsule, twice a day, in two weeks, once every 12 hours, after meal. Intervention 2: Control group: naproxen c

Sponsors

Kerman University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to No maximum

Inclusion criteria

Inclusion criteria: Men and women over 14 years of age Patients who be able to respond to the mentioned forms Patients wishing to enter the study

Exclusion criteria

Exclusion criteria: Pregnancy and lactation in women Patients with Diabetes Mellitus patients who take statin drugs Sensitivity to Fenugreek or other herbs Patients with history of coagulation disorders Patients undergoing orthodontic or orthopedic procedures Patients treated with anti psychotropic, anti-inflammatory and analgesic drugs and splint therapy Patients with dental caries that imitate pain in the head and face Patients with periodontal problems Patients with pathologic problems in the head and face

Design outcomes

Primary

MeasureTime frame
Reduce pain in Visual Analogue Scale and Brief Pain Inventory questionnaire. Timepoint: at beginning of the study and after 14th , 28th days of the beginning of the study. Method of measurement: Visual Analogue Scale and Brief Pain Inventory of pain questionnaire.

Secondary

MeasureTime frame
GI upset. Timepoint: Two and four weeks after drug administration. Method of measurement: Patient claim and Questionnaire fullfilment.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehdi Ansari

Kerman University of Medical Sciences

mansari@kmu.ac.ir+98 34 3132 5022

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026